Price $1.15 |
Market Cap
14.3M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.7
|
P/S
-
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-16.9K
|
FCF
-1.8
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-92.10%
|
ROI
-
|
|
ROA
-82.30%
|
EPS Growth
-37.40%
|
Current Ratio
8.9
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| IRIDEX Corporation (IRIX) | $10.08 | - | - | 103M | Strong Buy |
| InfuSystem Holdings Inc (INFU) | $2.19 | - | - | 43.2M | Strong Buy |
| Champions Oncology Inc (CSBR) | $3.38 | - | - | 33.3M | Strong Buy |
| Biostar Pharmaceuticals Inc (BSPM) | $1.23 | - | - | 3.6M | Strong Buy |
| MGC Diagnostics Corp (MGCD) | $8.11 | - | - | 34.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
